Literature DB >> 3392047

Translational regulation of B19 parvovirus capsid protein production by multiple upstream AUG triplets.

K Ozawa1, J Ayub, N Young.   

Abstract

The B19 parvovirus produces two capsid proteins in strikingly different quantities (VP1 less than 4%, VP2 greater than 96%) from overlapping RNAs that are derived from the same transcription unit. Immediately upstream from the VP1 translation initiation site is an unusual sequence containing multiple ATG triplets. During RNA processing this sequence is spliced out of VP2 RNA. To test the regulatory role on translation of this sequence containing upstream AUGs, synthetic RNAs were produced in vitro by T7 RNA polymerase from various plasmid constructions. Translation of VP1 RNA was very inefficient compared to VP2 RNA in a cell-free system, indicating that capsid protein production was regulated at the level of translation. Removal of upstream AUG sequences from VP1 RNA greatly increased the efficiency of translation. Conversely, the addition of the same AUG-rich sequence upstream of the initiation site of VP2 decreased its translation. These data indicate that an upstream AUG-rich region acts as a negative regulatory element in the translational control of B19 capsid protein production.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392047

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

2.  Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs.

Authors:  S Schwartz; B K Felber; G N Pavlakis
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

3.  The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells.

Authors:  C Pallier; A Greco; J Le Junter; A Saib; I Vassias; F Morinet
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Translational control of germ cell-expressed mRNA imposed by alternative splicing: opioid peptide gene expression in rat testis.

Authors:  J E Garrett; M W Collard; J O Douglass
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

5.  Characterization of the structural gene promoter of Aedes aegypti densovirus.

Authors:  T W Ward; M W Kimmick; B N Afanasiev; J O Carlson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Efficiency of reinitiation of translation on human immunodeficiency virus type 1 mRNAs is determined by the length of the upstream open reading frame and by intercistronic distance.

Authors:  B G Luukkonen; W Tan; S Schwartz
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus.

Authors:  S Kajigaya; T Shimada; S Fujita; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

8.  Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.

Authors:  C H Srivastava; R J Samulski; L Lu; S H Larsen; A Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins.

Authors:  C S Brown; J W Van Lent; J M Vlak; W J Spaan
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

10.  Expression of Aleutian mink disease parvovirus proteins in a baculovirus vector system.

Authors:  J Christensen; T Storgaard; B Bloch; S Alexandersen; B Aasted
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.